Enhancing bone regeneration by combining mesenchymal stem cell sheets with β‐TCP/COL‐I scaffolds. Issue 5 (3rd November 2017)

• Record Type: Journal Article
• Authors: Lin, Jun; Shao, Jiaqi; Juan, Li; Yu, Wenke; Song, Xiaojia; Liu, Pengruofeng; Weng, Wenjian; Xu, Jinghong; Mehl, Christian
• Is Part Of: Journal of biomedical materials research. Volume 106:Issue 5(2018)
• Page Start: 2037
• Page End: 2045
• Publication Date: 2017-11-03
• Subjects: mesenchymal stem cells -- β‐TCP/COL‐I scaffold -- bone regeneration -- ELISA -- quantitative real‐time polymerase chain reaction; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.b.34003
• Languages: English
• ISSNs: 1552-4973

Abstract

Abstract: The combination of bone marrow‐derived mesenchymal stem cells (BMSCs) and biological scaffolds has been demonstrated to be a promising strategy for bone regeneration. However, this method does not result in satisfactory bone regeneration, because the BMSCs are dispersed in the biological scaffolds. The current study developed a new bone regeneration system, which combines synthetic porous three‐dimensional scaffolds of β‐TCP/COL‐I composite with cultured osteogenic sheets of BMSCs. Activity of alkaline phosphatase (ALP), a marker of bone regeneration, was assayed in vitro using enzyme‐linked immunosorbent assays and quantitative real‐time polymerase chain reaction. In vivo bone regeneration was assayed in male nude mice. The study samples were BMSC sheet, scaffold/scattered BMSCs, scaffold/BMSC sheet, and scaffold alone. The samples were implanted dorsally in the mice. In vitro analysis showed that β‐TCP/COL‐I scaffold combined with BMSC sheets significantly upregulated both gene expression and protein levels of ALP, osteocalcin, and osteopontin. Histological and micro‐computed tomography showed that the only implants that demonstrated new bone formation after 4 weeks were scaffold/BMSC sheet implants. These results underscore the crucial requirement of a synergistic effect of β‐TCP/COL‐I scaffolds and BMSC sheets. This could be a promising novel strategy for bone tissue engineering. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2037–2045, 2018.